Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice

Published:2007-10 Issue:9 Volume:18 Page:1081-1091
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Santucci Luca,Mencarelli Andrea,Renga Barbara,Ceccobelli Daniela,Pasut Gianfranco,Veronese Francesco M.,Distrutti Eleonora,Fiorucci Stefano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference47 articles.

1. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer;Poole;N Engl J Med,2006

2. Treatment of acute lymphoblastic leukemia;Pui;N Engl J Med,2006

3. Doxorubicin-induced cardiomyopathy;Singal;N Engl J Med,1998

4. Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients;Jensen;Ann Oncol,2002

5. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials;Swain;Cancer,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug–polymer conjugates: Challenges, opportunities, and future prospects in clinical trials;Polymer-Drug Conjugates;2023

2. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment;Bioscience Reports;2022-07

3. Nanocarriers for Smart Therapeutic Strategies to Treat Drug-Resistant Tumors: A Review;ASSAY and Drug Development Technologies;2022-07-01

4. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules;WIREs Nanomedicine and Nanobiotechnology;2020-12-14

5. The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance;International Journal of Molecular Sciences;2020-01-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3